Featured Publications
Oxygen-Sensitive MRI: A Predictive Imaging Biomarker for Tumor Radiation Response?
Arai TJ, Yang DM, Campbell JW, Chiu T, Cheng X, Stojadinovic S, Peschke P, Mason RP, Int J Radiat Oncol Biol Phys 2021 Mar
Preclinical Applications of Multi-Platform Imaging in Animal Models of Cancer.
Serkova NJ, Glunde K, Haney CR, Farhoud M, DeLille A, Redente EF, Simberg D, Westerly DC, Griffin L, Mason RP, Cancer Res 2020 Dec
Evaluating online filtering algorithms to enhance dynamic multispectral optoacoustic tomography.
O'Kelly D, Guo Y, Mason RP, Photoacoustics 2020 Sep 19 100184
Oxygen-enhanced optoacoustic tomography reveals the effectiveness of targeting heme and oxidative phosphorylation at normalizing tumor vascular oxygenation.
Ghosh P, Guo Y, Ashrafi A, Chen J, Dey S, Zhong S, Liu J, Campbell J, Konduri PC, Gerberich J, Garrosian M, Mason RP, Zhang L, Liu L, Cancer Res. 2020 Jun
Examining correlations of oxygen sensitive MRI (BOLD/TOLD) with [18F]FMISO PET in rat prostate tumors.
Zhou H, Chiguru S, Hallac RR, Yang D, Hao G, Peschke P, Mason RP, Am J Nucl Med Mol Imaging 2019 9 2 156-167
The vascular disrupting agent combretastatin A-4 phosphate causes prolonged elevation of proteins involved in heme flux and function in resistant tumor cells.
Dey S, Kumari S, Kalainayakan SP, Campbell J, Ghosh P, Zhou H, FitzGerald KE, Li M, Mason RP, Zhang L, Liu L Oncotarget 2018 Jan 9 3 4090-4101
Tumor physiological changes during hypofractionated stereotactic body radiation therapy assessed using multi-parametric magnetic resonance imaging.
Zhou H, Zhang Z, Denney R, Williams JS, Gerberich J, Stojadinovic S, Saha D, Shelton JM, Mason RP Oncotarget 2017 Mar
Developing oxygen-enhanced magnetic resonance imaging as a prognostic biomarker of radiation response.
White DA, Zhang Z, Li L, Gerberich J, Stojadinovic S, Peschke P, Mason RP Cancer Lett. 2016 Jun 380 1 69-77
A role for dynamic contrast-enhanced magnetic resonance imaging in predicting tumour radiation response.
Hallac RR, Zhou H, Pidikiti R, Song K, Solberg T, Kodibagkar VD, Peschke P, Mason RP Br. J. Cancer 2016 May 114 11 1206-11
Dynamic oxygen challenge evaluated by NMR T1 and T2 * - insights into tumor oxygenation.
Zhao D, Pacheco-Torres J, Hallac RR, White D, Peschke P, Cerdán S, Mason RP NMR Biomed 2015 Jun
